News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Scott Kathleen D.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2023 |
4
| Scott Kathleen D. (CFO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $8.42, valued at
$421k
|
|
| 12/01/2022 |
4
| Scott Kathleen D. (CFO) has filed a Form 4 on ARS Pharmaceuticals, Inc.|
Txns:
| Bought 8,250 shares
@ $6.2432, valued at
$51.5k
|
|
| 10/07/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 11,359 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,826 shares
@ $0 |
|
| 01/05/2022 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 5,000 options to buy
@ $1.88, valued at
$9.4k
|
|
| 08/17/2021 |
4
| Scott Kathleen D. (Director) has filed a Form 4 on Dermata Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $7, valued at
$70k
|
|
| 08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|